ArticleInternational journal of molecular medicine2017

Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.

Yan-Ling Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.